Borena Wegene, Luckner-Hornischer Anita, Katzgraber Franz, Holm-von Laer Dorothee
Division of Virology, Medical University of Innsbruck, Austria.
Local Public Health Department, Austria.
Papillomavirus Res. 2016 Dec;2:173-177. doi: 10.1016/j.pvr.2016.10.001. Epub 2016 Oct 19.
Austria introduced a school-based gender-neutral human papillomavirus (HPV) immunization program in February 2014. In order to assure high coverage, factors influencing acceptance of the vaccine need to be identified. In this study we aim to assess parents' attitude and related socio-demographic factors in relation to the newly implemented gender-neutral, school-based HPV Immunization program.
Parents of 4th grade school children in 20 randomly selected primary schools were asked to fill out questionnaires on socio-demographic factors and on the level of information and attitude towards HPV infection and HPV vaccine.
A total of 439 parents with 449 vaccine eligible children participated in the study. Fifty nine percent of vaccine eligible girls and 51.8% of eligible boys received the first dose of the vaccine. Fear of side effects and child being too young for the vaccine were the most commonly cited reasons by parents electing not to let child receive the vaccine. Children who had received other school-based vaccines have more than fifteen times higher probability of receiving HPV vaccine. To have received HPV-related information from physicians positively influenced vaccine acceptance (OR (95% CI)=1.60 (1.06-2.43)). Higher paternal (fathers') educational status significantly increased the chances of a male child to be HPV vaccinated (OR (95% CI)=2.45 (1.29-4.78)).
Despite the efforts to provide HPV vaccine free-of-costs and as a school-based program, the study found that a significant proportion of vaccine eligible children failed to receive the vaccine. Involvement front line physicians and men with higher educational status may be utilised by public health policy makers in the effort to increase awareness. For a better acceptability of the vaccine, there is a need to consider lifting the age of "eligibility" for the school-based vaccination program.
奥地利于2014年2月推出了一项基于学校的性别中立型人乳头瘤病毒(HPV)免疫计划。为确保高接种率,需要确定影响疫苗接受度的因素。在本研究中,我们旨在评估家长对新实施的基于学校的性别中立型HPV免疫计划的态度及相关社会人口学因素。
在20所随机选取的小学中,四年级学生的家长被要求填写关于社会人口学因素以及对HPV感染和HPV疫苗的信息了解程度与态度的问卷。
共有439名家长及449名符合疫苗接种条件的儿童参与了研究。符合疫苗接种条件的女孩中有59%、男孩中有51.8%接种了第一剂疫苗。家长选择不让孩子接种疫苗最常提及的原因是担心副作用以及孩子年龄太小不适合接种疫苗。接种过其他学校提供疫苗的儿童接种HPV疫苗的可能性高出十五倍以上。从医生处获得HPV相关信息对疫苗接受度有积极影响(比值比(95%置信区间)=1.60(1.06 - 2.43))。父亲教育程度较高显著增加了男性儿童接种HPV疫苗的几率(比值比(95%置信区间)=2.45(1.29 - 4.78))。
尽管努力提供免费HPV疫苗并将其作为一项基于学校的计划,但研究发现,相当一部分符合疫苗接种条件的儿童未能接种疫苗。公共卫生政策制定者可利用一线医生及教育程度较高男性的参与来提高认识。为提高疫苗的接受度,有必要考虑提高基于学校的疫苗接种计划的“符合条件”年龄。